new semaglutide drugs Novo Nordisk's weight-loss pill wins FDA approval Popular obesity drug fails in
Description
Dulaglutide and efpeglenatide reduced albuminuria and the risk of a composite kidney end point in two CV outcomes trials involving patients with type 2 diabetes at early stages of CKD (33,34)
The reality is more nuanced: while some people experiment with extended intervals, clinical evidence and real-world outcomes show that consistent, appropriately-timed dosing produces better metabolic outcomes
And within a year, people regained two-thirds of the weight they'd lost
Sun Pharma, like Dr Reddy's Lab, can't sell semaglutide-based products in India until March 2026 when Novo Nordisks patent expires December 10, 2025 / 13:50 IST semaglutide Viswanath Pilla is a business journalist with 16 years of reporting experience
(iii) lack of specificity, with broad immunosuppression increasing the risk of infections and malignancy
Most patients begin noticing changes in appetite and eating habits within the first 2-4 weeks
